雷洛昔芬治疗绝经后妇女骨质疏松症的系统评价.docVIP

雷洛昔芬治疗绝经后妇女骨质疏松症的系统评价 【摘要数字化期刊全文数据库患者腰椎BMD升高达2.39%，且60mg/d剂量提高腰椎BMD强于30mg/d组，但60mg/d与120mg/d以上剂量组间效果无差别能有效降低椎体骨折发生率达40%。尚无证据支持能降低非椎体骨折发生率关键词雷洛昔芬绝经骨质疏松系统评价 Raloxifene Treatment in Postmenopausal Women With Osteoporosis: A Systematic Reviews HUANG Tao, LIU shiqing , ZHANG Chun ,LIAO Qi, ZHAO Qi,. Department of Orthopedics, Renmin Hospital of Wuhan University. Wuhan 430060, China [Abstract] Objective Evaluation of raloxifene treatment efficacy and safety of postmenopausal osteoporosis. Methods We searched MEDLINE, EMBASE, Cochrane Library Controlled Clinical Trial Register, the Chinese Biomedica